TY  - JOUR
AU  - Marziliano, Allison
AU  - Diefenbach, Michael A
AU  - Hudson, Shawna V
AU  - Tagai, Erin K
AU  - Handorf, Elizabeth A
AU  - Bator, Alicja
AU  - Miller, Suzanne M
PY  - 2022
DA  - 2022/3/21
TI  - Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial
JO  - J Med Internet Res
SP  - e27890
VL  - 24
IS  - 3
KW  - prostate cancer
KW  - cancer survivorship
KW  - web-based resource
KW  - monitoring style of coping
KW  - cancer
KW  - survivorship
KW  - eHealth
KW  - emotions
KW  - interpersonal
AB  - Background: Many prostate cancer (PC) survivors experience disease and treatment-related symptomatology in both the physical and psychosocial domains. Although the benefits and barriers to using web-based resources for cancer patients are well-documented, less research has focused on the personal characteristics important for efficient tailoring and targeting of information that are associated with usage. Objective: We used the Cognitive-Social Health Information Processing (C-SHIP) framework to guide our exploration of personal characteristics associated with use of PROGRESS, an informational PC survivorship website that addresses physical, emotional, interpersonal, and practical concerns relevant for PC survivors. Methods: PC survivors (N=217) were randomized to the intervention arm (PROGRESS) of a randomized controlled trial. Of those randomized to the intervention arm, 84 used PROGRESS, and 133 did not use PROGRESS. Multivariable analyses evaluated demographic and psychosocial characteristics (eg, style of coping, health literacy, self-efficacy, affective states of depression, anxiety, and fatigue) associated with website use. Results: A larger proportion of non-Hispanic White (68/160, 42.5%), compared with non-Hispanic Black (9/40, 23%), participants used PROGRESS (P<.001). Further, PROGRESS users were older in age (P<.001), had a monitoring style of coping (P=.01), and were less depressed (P=.004), anxious (P=.02), and fatigued (P<.001) than nonusers. Education, income, health literacy, blunting style of coping, self-efficacy, and treatment type (radiation therapy or surgery) were not significantly related to use. On multivariable analyses, race (OR 0.28, P<.001), age (OR 1.05, P<.001), monitoring style of coping (OR 1.27, P=.02), and overall mood (OR 0.98, P<.001) remained significant. Conclusions: A combination of monitoring and low levels of negative affect were associated with website use. Additionally, users were older, non-Hispanic White survivors. To ensure that important survivorship-relevant information reaches users, future efforts need to focus on enhancing patient engagement. Trial Registration: ClinicalTrials.gov NCT02224482; https://clinicaltrials.gov/ct2/show/NCT02224482 
SN  - 1438-8871
UR  - https://www.jmir.org/2022/3/e27890
UR  - https://doi.org/10.2196/27890
UR  - http://www.ncbi.nlm.nih.gov/pubmed/35311678
DO  - 10.2196/27890
ID  - info:doi/10.2196/27890
ER  -